» Articles » PMID: 7674315

Hereditary Nonpolyposis Colorectal Cancer: the Syndrome, the Genes, and Historical Perspectives

Overview
Specialty Oncology
Date 1995 Aug 2
PMID 7674315
Citations 107
Authors
Affiliations
Soon will be listed here.
Abstract

Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant disorder characterized by the occurrence within a family of multiple cases of colorectal cancer in the absence of gastrointestinal polyposis. The prevalence of this syndrome is not yet clear, but it may account for 1%-5% of all colorectal cancers. Prior to the identification of the genetic basis of this syndrome, the disease was recognized by the familial aggregation of colorectal cancers that had an early age of onset, an excess of proximally located, and often multiple, primary tumors, and an excess occurrence of cancers in certain other organs. The recent description of an abnormality called "microsatellite instability," present in almost all cancers from HNPCC patients and in about 12%-15% of sporadic cases, led to a series of discoveries that linked this type of genomic instability to a defect in the DNA mismatch repair (MMR) system. Independent investigators have identified four HNPCC genes: hMSH2 (a homologue of the prokaryotic DNA MMR gene MutS) and hMLH1, hPMS1, and hPMS2 (all homologues of the prokaryotic DNA MMR gene MutL). Mutations in each of the four genes have been found in the germline cells of HNPCC families. A major target for research in this area is the development of clinically practical screening tests for the genetic carrier state of HNPCC.

Citing Articles

A REVIEW TO HONOR THE HISTORICAL CONTRIBUTIONS OF PAULINE GROSS, ALDRED WARTHIN, AND HENRY LYNCH IN THE DESCRIPTION AND RECOGNITION OF INHERITANCE IN COLORECTAL CANCER.

Campos F, Bustamante-Lopez L, Carneiro DAlbuquerque L, Ribeiro Junior U, Herman P, Martinez C Arq Bras Cir Dig. 2024; 37:e1812.

PMID: 38958348 PMC: 11216406. DOI: 10.1590/0102-6720202400019e1812.


Preimplantation genetic testing for embryos predisposed to hereditary cancer: Possibilities and challenges.

Albujja M, Al-Ghedan M, Dakshnamoorthy L, Pla Victori J Cancer Pathog Ther. 2024; 2(1):1-14.

PMID: 38328708 PMC: 10846329. DOI: 10.1016/j.cpt.2023.05.002.


A Case of Lynch Syndrome-Associated Colorectal Adenocarcinoma in a 19-Year-Old Female Patient.

Iqbal A, Rabat S, Kaur R, Waqas M, Badar S, Haider F Cureus. 2023; 15(11):e48740.

PMID: 38094538 PMC: 10718292. DOI: 10.7759/cureus.48740.


Prevalence and Clinical Implications of Mismatch Repair-Proficient Colorectal Cancer in Patients With Lynch Syndrome.

Ranganathan M, Sacca R, Trottier M, Maio A, Kemel Y, Salo-Mullen E JCO Precis Oncol. 2023; 7:e2200675.

PMID: 37262391 PMC: 10309569. DOI: 10.1200/PO.22.00675.


Cohort profile: population-based cohorts of patients with colorectal cancer and of their relatives in Geneva, Switzerland.

Benhamou S, Fournier E, Puppa G, McKee T, Ris F, Rubbia-Brandt L BMJ Open. 2022; 12(8):e063914.

PMID: 36008070 PMC: 9422819. DOI: 10.1136/bmjopen-2022-063914.